BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21417895)

  • 1. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors.
    Deisch J; Raisanen J; Rakheja D
    Pediatr Dev Pathol; 2011; 14(5):353-9. PubMed ID: 21417895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SWI/SNF-deficient tumors of the central nervous system: An update.
    Hasselblatt M; Kool M; Frühwald MC
    Clin Neuropathol; 2024; 43(1):2-9. PubMed ID: 37969088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Super-Enhancer Dysregulation in Rhabdoid Tumor Cells Is Regulated by the SWI/SNF ATPase BRG1.
    Jones CA; Wang J; Evans JR; Sisk HR; Womack CB; Liu Q; Tansey WP; Weissmiller AM
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors.
    Pekkarinen M; Nordfors K; Uusi-Mäkelä J; Kytölä V; Hartewig A; Huhtala L; Rauhala M; Urhonen H; Häyrynen S; Afyounian E; Yli-Harja O; Zhang W; Helen P; Lohi O; Haapasalo H; Haapasalo J; Nykter M; Kesseli J; Rautajoki KJ
    Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38499326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies.
    Andres S; Huang K; Shatara M; Abdelbaki MS; Ranalli M; Finlay J; Gupta A
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30979. PubMed ID: 38553892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of malignant rhabdoid tumors of the head and neck with combined chemotherapy and
    Duan C; Zheng L; Zhang D; Jin M; Su Y; Zhao W; Wang X; Zhao Q; Huang C; Zhang J; Zhang J; Ni X; Ma X
    Pediatr Investig; 2018 Mar; 2(1):53-55. PubMed ID: 32851232
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
    Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
    Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.
    Lobón-Iglesias MJ; Andrianteranagna M; Han ZY; Chauvin C; Masliah-Planchon J; Manriquez V; Tauziede-Espariat A; Turczynski S; Bouarich-Bourimi R; Frah M; Dufour C; Blauwblomme T; Cardoen L; Pierron G; Maillot L; Guillemot D; Reynaud S; Bourneix C; Pouponnot C; Surdez D; Bohec M; Baulande S; Delattre O; Piaggio E; Ayrault O; Waterfall JJ; Servant N; Beccaria K; Dangouloff-Ros V; Bourdeaut F
    Nat Commun; 2023 Oct; 14(1):6669. PubMed ID: 37863903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chromatin remodelling SWI/SNF subunit, Snr1, regulates neural stem cell determination and differentiation.
    Keegan SE; Haskins J; Simmonds AJ; Hughes SC
    Development; 2023 Jul; 150(13):. PubMed ID: 37294080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Malignant Rhabdoid Tumor Antigens as Biomarkers and Potential Therapeutic Targets.
    Hua T; Zeng Z; Chen J; Xue Y; Li Y; Sang Q
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Wilms' renal tumors in children: experience with 139 cases treated at a single center.
    Fang YW; Song HC; Sun N; Zhang WP
    BMC Urol; 2022 Jun; 22(1):89. PubMed ID: 35733141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis on diagnosis and treatments of 16 cases of extracranial malignant rhabdoid tumor in children.
    Xie S; Yang J; Ma Y; Li K; Dong K; Yao W
    Transl Cancer Res; 2022 Apr; 11(4):629-638. PubMed ID: 35571638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy.
    Chong WC; Jayasekara WSN; Vaghjiani VG; Parackal S; Sun C; Popovski D; Algar EM; Firestein R; Wood PJ; Khan S; Huang A; Ashley DM; Downie P; Cain JE
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling cancer progression using human pluripotent stem cell-derived cells and organoids.
    Zhang M; Vandana JJ; Lacko L; Chen S
    Stem Cell Res; 2020 Dec; 49():102063. PubMed ID: 33137568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example.
    Golan H; Shukrun R; Caspi R; Vax E; Pode-Shakked N; Goldberg S; Pleniceanu O; Bar-Lev DD; Mark-Danieli M; Pri-Chen S; Jacob-Hirsch J; Kanter I; Trink A; Schiby G; Bilik R; Kalisky T; Harari-Steinberg O; Toren A; Dekel B
    Stem Cell Reports; 2018 Sep; 11(3):795-810. PubMed ID: 30122444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis.
    Holsten T; Bens S; Oyen F; Nemes K; Hasselblatt M; Kordes U; Siebert R; Frühwald MC; Schneppenheim R; Schüller U
    Eur J Hum Genet; 2018 Aug; 26(8):1083-1093. PubMed ID: 29706634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor.
    Zuccarini M; Giuliani P; Ziberi S; Carluccio M; Iorio PD; Caciagli F; Ciccarelli R
    Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29462960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.
    Vitte J; Gao F; Coppola G; Judkins AR; Giovannini M
    Nat Commun; 2017 Aug; 8(1):300. PubMed ID: 28824165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and clinical significance of SALL4 in breast cancer.
    Dirican E; Akkiprik M
    Tumour Biol; 2016 Sep; 37(9):11701-11709. PubMed ID: 27444278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways.
    Chun HE; Lim EL; Heravi-Moussavi A; Saberi S; Mungall KL; Bilenky M; Carles A; Tse K; Shlafman I; Zhu K; Qian JQ; Palmquist DL; He A; Long W; Goya R; Ng M; LeBlanc VG; Pleasance E; Thiessen N; Wong T; Chuah E; Zhao YJ; Schein JE; Gerhard DS; Taylor MD; Mungall AJ; Moore RA; Ma Y; Jones SJM; Perlman EJ; Hirst M; Marra MA
    Cancer Cell; 2016 Mar; 29(3):394-406. PubMed ID: 26977886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.